ArticleBMJ open2016

Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).

Esther Peters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.